medigraphic.com
SPANISH

Medicina Interna de México

Colegio de Medicina Interna de México.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2021, Number 5

<< Back Next >>

Med Int Mex 2021; 37 (5)

Acute myocarditis, unusual manifestation of visceral loxoscelism

Hernández-Ortega AP, González-Guerrero MC, Arias-Amaral J, Becerra-Martínez JM
Full text How to cite this article

Language: Spanish
References: 18
Page: 867-873
PDF size: 403.38 Kb.


Key words:

Loxosceles, Antivenom, Acute kidney injury, Infections, Multiorgan failure.

ABSTRACT

Background: Loxoscelism is a clinical picture resulting from the bite of the spider of the genus Loxosceles, it constitutes an important public health problem in several Latin American countries, including Mexico.
Clinical case: A 31-year-old male patient with diagnosis of loxoscelism, presenting acute myocarditis as an unusual manifestation and multiple organ failure. Despite of an unfavorable prognosis, outcome was good.
Conclusions: Studies are needed to implement diagnostic criteria that require laboratory studies, such as markers of hemolysis and sphingomyelinase D concentrations.


REFERENCES

  1. Vetter RS. Arachnids submitted as suspected brown recluse spiders (Araneae: Sicariidae): loxosceles spiders are virtually restricted to their known distributions but are perceived to exist throughout the United States. J Med Entomol 2005; 42: 512-521. doi: 10.1093/jmedent/42.4.512.

  2. Saraco S, De Roodt A. Envenenamiento por animales ponzoñosos. Loxoscelismo. ATA 2005; 67: 45-9.

  3. Da Silva P, Bertoni R, Appel M, Mangili O, Gremsky W, Sanches S. Brown spider and loxoscelism. Toxicon 2004; 44: 693-709. doi: 10.1016/j.toxicon.2004.07.012.

  4. Swanson DL, Vetter RS. Loxoscelism. Clin Dermatol 2006; 24: 213-221. doi: 10.1016/j.clindermatol.2005.11.006.

  5. Schenone H. Cuadros tóxicos producidos por mordeduras de araña en Chile: latrodectismo y loxoscelismo. Rev Méd Chile 2003; 131: 437- 44. http://dx.doi.org/10.4067/S0034- 98872003000400013.

  6. Vetter RS. Myths about spider envenomations and necrotic skin lesions. Lancet 2004; 364: 484-485. https://doi. org/10.1016/S0140-6736(04)16824-4.

  7. Moranchel-García L, Pineda-Galindo LF, et al. Evolución clínica de pacientes con loxoscelismo sistémico y dermonecrótico en un hospital de tercer nivel. Med Int Méx 2017; 33 (1): 18-27.

  8. GPC. Diagnóstico y tratamiento de mordeduras por arañas venenosas. Consejo de salubridad General. SSA 523-11. CENETEC. México.

  9. Hurtado-Valenzuela JG, Sotelo-Cruz N, Ibarra-Silva R. Envenenamiento por Loxosceles reclusa (araña “parda”). Rev Mex Pediatr 2005; 72: 85-88.

  10. Ministerio de Salud de Chile. Efectividad del suero antiloxosceles. Síntesis de evidencia, Santiago de Chile 2004.

  11. De Roodt AR, Salomon OD, Lloveras SC, Orduña TA. Envenenamiento por arañas del género Loxosceles. Medicina (Buenos Aires) 2002; 62: 83-94.

  12. Malaque CM, Santoro ML, Cardoso JL, Conde MR, Novaes CT, Risk JY, Franca FO, de Medeiros CR, Fan HW. Clinical picture and laboratorial evaluation in human loxoscelism. Toxicon 2011; 58: 664-671.

  13. Kimori-Okamoto C, van den Berg CW, Masashi M, Gonçalves-de Andrade R, et al. Tetracycline reduces kidney damage induced by loxosceles spider venom. Toxins (Basel) 2017; 9 (3): 90. doi: 10.3390/toxins9030090.

  14. Andersen RJ, Campoli J, Johar SK, Schumacher KA, Allison EJ Jr. Suspected brown recluse envenomation: a case report and review of different treatment modalities. J Emerg Med 2011; 41 (2): e31-7. doi: 10.1016/j.jemermed. 2009.08.055.

  15. Howlett JG, McKelvie RS, Arnold JM, Costigan J, Dorian P, Ducharme A, Estrella-Holder E, Ezekowitz JA, et al. Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol 2009; 25 (2): 85-105.

  16. De Cobelli F, Pieroni M, Esposito A, Chimenti C, et al. Delayed gadolinium-enhanced cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias. J Am Coll Cardiol 2006; 47 (8): 1649-54. doi: 10.1016/j.jacc.2005.11.067.

  17. Friedrich MG, Marcotte F. Cardiac magnetic resonance assessment of myocarditis. Circ Cardiovasc Imaging 2013; 6: 833. https://doi.org/10.1161/CIRCIMAGING.113.000416.

  18. Aretz HT, Billingham ME, Edwards WD, et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1987; 1: 3-14.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Int Mex. 2021;37